Levocarnitine Supplementation Affects Adiponectin and Serum Lipid Levels in Type 2 Diabetic Mice

Authors

  • Shahida Parveen, Irfan Afzal Mughal, Noor-Ul-Ain Irfan, Ilqa Attique Ahmed, Amna Faruqi, Asma Irfan

DOI:

https://doi.org/10.53350/pjmhs22165324

Keywords:

Adiponectin, Levocarnitine, Lipids

Abstract

Objective: To ascertain the impact of levocarnitine on adiponectin and serum lipid levels in a T2DM mouse model.

Design of the study: Randomized controlled trial

Place and Duration of Study: Department of Physiology, Army Medical College, Rawalpindi from 1stSeptember 2015 to 31stAugust 2017.

Methodology: Forty healthy BALB/c mice, which were allocated to two groups. The mice were initially given a high-fat diet for a fortnight and then induction of T2DM was performed by injecting them with streptozotocin intraperitoneally. Group I was taken as diabetic control, and group II was given levocarnitine. After six additional days, blood samples were analyzed for insulin, adiponectin and lipids.

Results: Adiponectin blood level was significantly increased and an improvement in lipid profile was observed in the levocarnitine group, when compared with control group. In the diabetic control group, a positive significant correlation was observed between (HDL-C) high density lipoprotein levels and adiponectin levels. Additionally, this group also showed total cholesterol and low-density lipoproteins (LDL-C) are negatively proportionate to the adiponectin.

Conclusions: The addition of levocarnitine increases serum adiponectin levels and improves dyslipidaemia in a type of diabetic rats.

Downloads

How to Cite

Shahida Parveen, Irfan Afzal Mughal, Noor-Ul-Ain Irfan, Ilqa Attique Ahmed, Amna Faruqi, Asma Irfan. (2022). Levocarnitine Supplementation Affects Adiponectin and Serum Lipid Levels in Type 2 Diabetic Mice. Pakistan Journal of Medical & Health Sciences, 16(05), 324. https://doi.org/10.53350/pjmhs22165324

Issue

Vol. 16 No. 05 (2022): Pakistan Journal of Medical & Health Sciences

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.